Caredx, INC Form 4 insider transactions

Alexander L. Johnson, President of Patient and Testing Services at CareDx, Inc., reports disposition of shares to cover tax obligations.

Director William Hagstrom reports acquisition of 10,570 shares of common stock and 16,048 stock options in CareDx, Inc.

Arthur Torres, a director at CareDx, Inc., reported the acquisition of 10,570 shares of common stock and 16,048 stock options on June 14, 2024.

Director Peter Maag reports acquisition of CareDx shares and stock options in a recent SEC filing.

Director Hannah Valantine reports acquisition of CareDx common stock and stock options.

Michael Goldberg, a director at CareDx, Inc., reported the acquisition of 10,570 restricted stock units and 16,048 stock options on June 14, 2024.

Director Fred E. Cohen reports acquisition of CareDx stock and options via restricted stock units and stock options.

Director George Bickerstaff reports acquisition of CareDx shares and stock options.

Director Richard Bryan Riggsbee reports acquisition of CareDx shares and stock options through grants.

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., reported the disposal of 1,713 shares of common stock to cover tax obligations related to vesting restricted stock units on June 6, 2024.

CareDx's Chief Financial Officer, Abhishek Jain, reported a transaction involving the withholding of shares to cover tax obligations related to vested restricted stock units.

Director George Bickerstaff exercised stock options and disposed of 5,255 shares of CareDx, Inc. at a price of $10 on May 14, 2024.

Jeffrey Adam Novack, Secretary and General Counsel of CareDx, Inc., sold 1,905 shares of common stock on May 1, 2024, to cover tax obligations related to vesting restricted stock units.

Abhishek Jain, CFO of CareDx, Inc., reports a transaction involving the withholding of shares to cover tax obligations related to vested restricted stock units.

Alexander L. Johnson, President of Patient and Testing Services at CareDx, Inc., reports the disposal of 7,371 shares of common stock to cover tax obligations related to vesting restricted stock units.

Peter Maag, a director at CareDx, Inc., exercised stock options to acquire 13,281 shares of common stock at a price of $5.27 on April 29, 2024.

CareDx's Chief Financial Officer, Abhishek Jain, reports a transaction involving the withholding of shares to cover tax obligations related to vested restricted stock units.

Abhishek Jain, CFO of CareDx, Inc., reports the withholding of 235 common stock shares by the issuer to cover tax obligations related to vesting restricted stock units on April 8, 2024.

Abhishek Jain, CFO of CareDx, Inc., files an amendment to a previous Form 4 to report the grant of 174,520 restricted stock units (RSUs) inadvertently omitted from the original filing.

Alexander L. Johnson, President of Patient and Testing Services at CareDx, Inc., amends a previous SEC Form 4 filing to include a grant of restricted stock units inadvertently omitted, impacting the reported beneficial ownership.

Director Peter Maag acquired 1,249 shares of CareDx common stock on April 4, 2024, as part of the company's Outside Director Compensation Policy.

Michael Goldberg, a director at CareDx, Inc., acquired 3,686 shares of common stock on April 4, 2024, as part of the company's Outside Director Compensation Policy.